Current Opinion in Endocrinology and Diabetes was launched in 1994. It is one of a successful series of review journals whose unique format is designed to provide a systematic and critical assessment of the literature as presented in the many primary journals. The fields of endocrinology and diabetes are divided into 9 sections that are reviewed once a year. Each section is assigned a Section Editor, a leading authority in the area, who identifies the most important topics at that time. Here we are pleased to introduce one of the Journal's Section Editors for this issue.
Daniel Baran, MD
Dr Baran is a National Scientific Director for Merck & Co., Inc. He received his medical degree from the University of Rochester, Rochester, New York. Following his training in internal medicine in Rochester, he was a National Institute of Health Fellow in Endocrinology at the Jewish Hospital of St Louis/Washington University School of Medicine. He has held faculty positions at Washington University School of Medicine and University of Rochester, and has served on the faculty at the University of Massachusetts, Worcester, Massachusetts, since 1984, where he currently is adjunct Professor of Orthopedics, Medicine and Cell Biology. Dr Baran has published extensively in the field of osteoporosis, conducting both basic and human osteoporosis research.